suffering
[용어속성] Term
[Recommendations for the management of the patient with chronic renal disease with SARS-CoV-2]
[SARS-CoV-2 만성신질환자 관리를 위한 권고사항]
Case Reports
[키워드] advanced age
Affect
Chronic kidney disease
chronic renal disease
clinical
Clinical protocols
Contagion
COVID-19
distribution
English
epidemia
Factors
Health
Hemodialysis
Hemodialysis, Kidney transplantation
Immunosuppression
include
initial
initial stage
Isolation
Kidney disease
Kidney diseases
management
measure
more difficult
Pandemia
para
Patient
professional
professionals
protocol
protocols
renal
renal disease
risk
SARS-CoV-2
SARS-CoV-2 pandemic
Spanish
Stage
suffering
technique
the epidemic
the patient
transfer
[DOI] 10.1016/j.enfcli.2020.05.017 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1016/j.enfcli.2020.05.017 PMC 바로가기 [Article Type] Case Reports
Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis
Oncology
[키워드] 95% CI
95% confidence interval
acute respiratory syndrome
affected
all age groups
Analysis
analyzed
calculated
Cancer
cancer patient
Care
caused
Chi square test
childhood cancer
children
clinical
Cochrane Library
Complication
conducted
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
cross-sectional
eligible
England
Google Scholar
hematological
Hematological malignancy
heterogeneity
Hospitalization
Hospitalized
intensive care
intubation
JAMA
journal
Lancet
LILACS
measure
Medicine
medRxiv
Meta-analysis
Mortality
Nature
New
not different
Odds ratio
outcomes
Oxford
pandemic
Patient
patients with COVID-19
pediatric
performed
random effect
registry
Result
risk
risk factor
SARS-CoV-2
Science
severe acute respiratory syndrome coronavirus 2
solid tumor
solid tumors
statistical analysis
statistically significant difference
stratified
suffering
survival
systematic review
Tumor
university
Ventilation
ventilatory support
was performed
WHO
[DOI] 10.3389/fonc.2020.608282 PMC 바로가기 [Article Type] Oncology
[DOI] 10.3389/fonc.2020.608282 PMC 바로가기 [Article Type] Oncology
Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial
중증 급성 호흡기 증후군이 있는 COVID-19 환자 관리에 대한 중국 전통 의학 Maxingshigan-Weijing의 효능: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
acute respiratory syndrome
acute respiratory syndrome coronavirus
addition
administration
Affiliated Hospital
age
allergic
allergies
anorexia
anti-bacterial
Anti-viral
anticipated
Anxiety
Arm
asked
Asymptomatic
automatically
aversion
blinded
Blinding
Blood tinged
blood tinged sputum
both groups
Care
carried
center
checklist
Chenpi
chest pain
chest X-ray
Chinese
Chinese Clinical Trial Registry
Chinese herbal medicines
clinical
clinical symptom
clinical trials
clinically
Cold
comparator Patients
composed
control group
Controlled trial
coronavirus
cough
COVID-19
COVID-19 patient
criteria
critical patient
critical patients
defined
diarrhea
disease
Diseases
dissemination
distension
Dizziness
dry mouth
dysphoria
effective
Efficacy
element
Eligible patients
ephedra
exclusion criteria
expectoration
female
Fever
Follow-up
four-point scale
Gypsum
H1N1
H1N1 influenza
headache
hematopoietic system
Herba Ephedra
herbal medicine
hospital
IBM
IBM Corp
IMPROVE
improvement
in both group
include
Inclusion
inclusion and exclusion criteria
inclusion criteria
individual
Influenza
Informed consent
Inpatient
Insomnia
Kaplan-Meier method
kidney
Kidney function
lactation
less
liver
log-rank test
malaise
male
management
Maxingshigan-weijing
mechanical ventilation
Medicine
Melon
Mild
mild clinical symptoms
multicenter
multiple organ failure
muscular
nasal
nasal obstruction
nausea
nausea and vomiting
negative test
nucleic acid
number
objective
open
Open-label
oral administration
outcome
participant
Patient
patients
Peach
pharyngalgia
Pneumonia
positive
Pregnancy
previous study
Primary outcome
Professor
proportion
protocol
Radix
random
random allocation
random number generator
randomisation
randomised
Randomized
Randomized controlled trial
randomly divided
receive
recruited
registry
reported
researcher
respiratory
Respiratory failure
respiratory symptom
Sample size
SARS-CoV-2
SARS-CoV-2 nucleic acid
Scoring
second
secondary
Secondary outcomes
Semen
sequence
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severity
Shock
Shortness of breath
statistical analysis
Statistical power
Statistics
status
Study protocol
suffering
supplementary material
supportive care
survival
survival time
sweating
Symptom
symptomatic
Symptoms
System
TCM
temperature
test results
the median
therapy
total score
Traditional
Traditional Chinese medicine
treated
Treatment
trial protocol
Trial registration
Trichosanthe
Trichosanthes Kirilowii
university
USA
Version
virus pneumonia
vomiting
website
wheezing
Winter
Withdrawal
[DOI] 10.1186/s13063-020-04970-3 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04970-3 PMC 바로가기 [Article Type] Letter
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study
Observational Study
[키워드] Abstract
average
both group
C-reactive protein (CRP
changed
clinically
Combination
combination regimen
combination therapy
Coronavirus disease 2019
COVID-19
determine
disease
effective therapy
Efficacy
Evidence
Follow-up
hospital
Hydroxychloroquine
indicated
Inpatient
Iran
laboratory parameter
laboratory-confirmed
lack
Length
Length of stay in hospitals (ALOS).
low-dose prednisolone
Novel coronavirus
oseltamivir
outcome
oxygen saturation
pandemic
Patient
patients
pharmacological
Platelet
Pneumonia
positive
Prednisolone
receiving
regimen
retrospective
Serum level
significant difference
SpO2
suffering
Tehran
temperature
the patient
therapeutic strategy
therapy for COVID-19
two groups
were recorded
with COVID-19
[DOI] 10.1007/s40199-020-00353-w PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1007/s40199-020-00353-w PMC 바로가기 [Article Type] Observational Study